Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Intracellular pH (pHi) refers to the measurement of the hydrogen ion concentration within the cytoplasm of a cell, typically maintained within a narrow range of 7.0 to 7.2 under physiological conditions (PMID: 21350449). It serves as a critical regulator of numerous cellular processes, including protein synthesis, enzyme kinetics, and the cell cycle, where even minor fluctuations can trigger or inhibit metabolic pathways (PMID: 29056289). While pHi is not a single molecular target like a protein or receptor, it is considered a therapeutic focal point, particularly in oncology, due to the 'inverted pH gradient' observed in cancer cells (PMID: 24721434). In malignant cells, the pHi is often more alkaline than in normal cells, which facilitates proliferation and helps evade apoptosis, while the extracellular environment becomes acidic to promote invasion (PMID: 32296062). Therapeutic strategies aimed at modulating intracellular pH focus on the inhibition of transport proteins and enzymes that regulate proton export, such as Sodium-hydrogen exchanger 1 (NHE1), Carbonic anhydrase IX (CA IX), and Monocarboxylate transporters (MCTs). By inducing intracellular acidification or preventing the maintenance of the alkaline state, drugs like Cariporide or CA IX inhibitors can selectively impair tumor cell survival and enhance the efficacy of chemotherapy (PMID: 28243160). Monitoring pHi remains a challenge in clinical settings, relying on advanced imaging techniques like MRS or specialized PET tracers to assess the metabolic and acid-base status of diseased tissues (PMID: 30127563).
Modulation of intracellular pH is typically achieved by inhibiting or activating specific membrane transporters and enzymes, such as sodium-hydrogen exchangers (NHEs), carbonic anhydrases (CAs), monocarboxylate transporters (MCTs), and vacuolar-type H+-ATPases (V-ATPases), which regulate the extrusion or buffering of protons and bicarbonate ions.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intracellular pH (pHi) (pHi).